USA - NYSE:NUS - US67018T1051 - Common Stock
The current stock price of NUS is 9.46 USD. In the past month the price decreased by -12.17%. In the past year, price increased by 31.99%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 50.94 | 30.84B | ||
| KVUE | KENVUE INC | 14.97 | 30.74B | ||
| ELF | ELF BEAUTY INC | 23.06 | 4.04B | ||
| BRBR | BELLRING BRANDS INC | 13.1 | 3.58B | ||
| COTY | COTY INC-CL A | 16.95 | 2.81B | ||
| IPAR | INTERPARFUMS INC | 14.74 | 2.48B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.74 | 795.63M | ||
| OLPX | OLAPLEX HOLDINGS INC | 12.69 | 677.09M | ||
| NATR | NATURES SUNSHINE PRODS INC | 21.36 | 354.21M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.5 | 340.18M | ||
| HNST | HONEST CO INC/THE | 43.17 | 288.19M | ||
| UPXI | UPEXI INC | N/A | 158.41M |
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. The company is headquartered in Provo, Utah and currently employs 3,100 full-time employees. The company has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. The company offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.
NU SKIN ENTERPRISES INC - A
Attn: D. Matthew Dorny, 75 West Center St
Provo UTAH 84601 US
CEO: Ritch N. Wood
Employees: 3100
Phone: 18013456100
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. The company is headquartered in Provo, Utah and currently employs 3,100 full-time employees. The company has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. The company offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.
The current stock price of NUS is 9.46 USD. The price decreased by -0.73% in the last trading session.
NU SKIN ENTERPRISES INC - A (NUS) has a dividend yield of 2.45%. The yearly dividend amount is currently 0.24.
NUS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
8 analysts have analysed NUS and the average price target is 7.65 USD. This implies a price decrease of -19.13% is expected in the next year compared to the current price of 9.46.
You can find the ownership structure of NU SKIN ENTERPRISES INC - A (NUS) on the Ownership tab.
The outstanding short interest for NU SKIN ENTERPRISES INC - A (NUS) is 4.77% of its float.
ChartMill assigns a technical rating of 1 / 10 to NUS. When comparing the yearly performance of all stocks, NUS turns out to be only a medium performer in the overall market: it outperformed 68.56% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to NUS. NUS has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months NUS reported a non-GAAP Earnings per Share(EPS) of 1.38. The EPS increased by 64.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.2% | ||
| ROA | 6.98% | ||
| ROE | 12.8% | ||
| Debt/Equity | 0.27 |
8 analysts have analysed NUS and the average price target is 7.65 USD. This implies a price decrease of -19.13% is expected in the next year compared to the current price of 9.46.
For the next year, analysts expect an EPS growth of 49.72% and a revenue growth -11.95% for NUS